BI Asset Management Fondsmaeglerselskab’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $59.5M | Sell |
468,644
-659,086
| -58% | -$77.1M | 0.47% | 39 |
|
|
2026
Q1 | $135M | Sell |
1,127,730
-229,569
| -17% | -$26.5M | 1.41% | 13 |
|
|
2025
Q4 | $142M | Buy |
1,357,299
+110,415
| +9% | +$10.4M | 1.25% | 12 |
|
|
2025
Q3 | $104M | Buy |
1,246,884
+254,350
| +26% | +$20.9M | 0.94% | 15 |
|
|
2025
Q2 | $78.6M | Buy |
992,534
+782,299
| +372% | +$62.2M | 0.77% | 25 |
|
|
2025
Q1 | $18.9M | Sell |
210,235
-146,844
| -41% | -$13.7M | 0.21% | 105 |
|
|
2024
Q4 | $35.5M | Sell |
357,079
-82,357
| -19% | -$8.49M | 0.37% | 52 |
|
|
2024
Q3 | $49.9M | Buy |
439,436
+125,873
| +40% | +$15M | 0.86% | 27 |
|
|
2024
Q2 | $38.8M | Buy |
313,563
+19,942
| +7% | +$2.57M | 0.64% | 33 |
|
|
2024
Q1 | $38.7M | Buy |
293,621
+24,930
| +9% | +$3.07M | 0.73% | 30 |
|
|
2023
Q4 | $29.3M | Sell |
268,691
-63,636
| -19% | -$6.61M | 0.62% | 38 |
|
|
2023
Q3 | $34.2M | Sell |
332,327
-407,453
| -55% | -$43.9M | 0.8% | 26 |
|
|
2023
Q2 | $85.4M | Buy |
739,780
+111,449
| +18% | +$12.7M | 2.02% | 5 |
|
|
2023
Q1 | $66.8M | Sell |
628,331
-120,740
| -16% | -$13M | 1.77% | 7 |
|
|
2022
Q4 | $83.1M | Buy |
749,071
+331,196
| +79% | +$33.9M | 2.21% | 5 |
|
|
2022
Q3 | $36M | Buy |
417,875
+24,045
| +6% | +$2.15M | 1.83% | 11 |
|
|
2022
Q2 | $35.9M | Sell |
393,830
-425
| -0.1% | -$37.7K | 1.53% | 11 |
|
|
2022
Q1 | $32.3M | Sell |
394,255
-47,745
| -11% | -$3.76M | 1.24% | 19 |
|
|
2021
Q4 | $33.9M | Buy |
442,000
+10,791
| +3% | +$859K | 1.25% | 15 |
|
|
2021
Q3 | $32.4M | Sell |
431,209
-24,562
| -5% | -$1.87M | 1.23% | 17 |
|
|
2021
Q2 | $35.4M | Sell |
455,771
-20,622
| -4% | -$1.53M | 1.36% | 13 |
|
|
2021
Q1 | $35M | Sell |
476,393
-116,942
| -20% | -$8.63M | 1.43% | 13 |
|
|
2020
Q4 | $46.3M | Buy |
593,335
+64,921
| +12% | +$4.97M | 2.02% | 7 |
|
|
2020
Q3 | $41.8M | Buy |
528,414
+31,568
| +6% | +$2.47M | 1.9% | 5 |
|
|
2020
Q2 | $36.7M | Buy |
496,846
+52,300
| +12% | +$3.94M | 1.88% | 4 |
|
|
2020
Q1 | $32.6M | Buy |
444,546
+36,440
| +9% | +$2.86M | 1.94% | 8 |
|
|
2019
Q4 | $35.4M | Sell |
408,106
-34,029
| -8% | -$2.79M | 1.68% | 17 |
|
|
2019
Q3 | $35.5M | Buy |
442,135
+21,484
| +5% | +$1.72M | 1.75% | 15 |
|
|
2019
Q2 | $33.7M | Buy |
420,651
+13,753
| +3% | +$1.05M | 1.6% | 21 |
|
|
2019
Q1 | $32.3M | Buy |
406,898
+86,105
| +27% | +$6.44M | 1.63% | 18 |
|
|
2018
Q4 | $23.4M | Buy |
+320,793
| New | +$22.6M | 1.5% | 16 |
|
|
2015
Q2 | – | Sell |
-245,966
| Closed | -$13.5M | – | 39 |
|
|
2015
Q1 | $13.5M | Sell |
245,966
-5,868
| -2% | -$332K | 1.32% | 20 |
|
|
2014
Q4 | $13.6M | Sell |
251,834
-27,039
| -10% | -$1.51M | 1.51% | 21 |
|
|
2014
Q3 | $15.8M | Buy |
278,873
+5,450
| +2% | +$306K | 1.91% | 20 |
|
|
2014
Q2 | $15.1M | Sell |
273,423
-22,427
| -8% | -$1.22M | 1.64% | 19 |
|
|
2014
Q1 | $16M | Buy |
+295,850
| New | +$15.3M | 1.94% | 17 |
|
Other funds holding MRK
BI Asset Management Fondsmaeglerselskab's MRK Position: Q2 2026 in Review
BI Asset Management Fondsmaeglerselskab reduced its Merck (MRK) stake by 58% in Q2 2026, selling an estimated $77.1M and leaving 468,644 shares worth $59.5M. The position accounts for 0.47% of the portfolio, ranked #39.
BI Asset Management Fondsmaeglerselskab first reported a position in MRK in Q1 2014 and has held it in 36 quarters since. The position peaked at $142M in Q4 2025. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- BI Asset Management Fondsmaeglerselskab held 468,644 shares of Merck worth $59.5M as of Q2 2026.
- BI Asset Management Fondsmaeglerselskab sold 659,086 Merck shares in Q2 2026, an estimated $77.1M.
- Merck made up 0.47% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #39 holding.
- BI Asset Management Fondsmaeglerselskab first reported a position in Merck in Q1 2014 and has held it in 36 quarters since.
- BI Asset Management Fondsmaeglerselskab's Merck position peaked at $142M in Q4 2025.
- 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.